Indoco Remedies

{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "250.65",
    "chg": 21.97,
    "chgp": "9.61%",
    "dir": 1,
    "prev_price": "228.68",
    "mcapval": "2,102.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE873D01024",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "14.88 lacs",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Q4 FY26: Mounting Losses Despite Revenue Growth Signal Deeper Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/indoco-remedies-q4-fy26-mounting-losses-despite-revenue-growth-signal-deeper-operational-crisis-3980302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemedies_quaterlyResult_3980302.png",
        "date": "2026-05-07 17:46:23",
        "description": "Indoco Remedies Ltd., the Mumbai-based pharmaceutical company with a market capitalisation of ₹2,102 crores, reported a consolidated net loss of ₹21.64 crores for Q4 FY26, representing a sequential deterioration of 27.36% from the previous quarter's loss of ₹29.79 crores. On a year-on-year basis, the loss widened by 46.42% compared to the ₹40.39 crores loss in Q4 FY25. Despite posting quarterly revenue growth of 6.79% quarter-on-quarter and 21.89% year-on-year to reach ₹475.61 crores, the company's profitability remains severely impaired by escalating interest costs and operational inefficiencies."
      },
      {
        "title": "Indoco Remedies Ltd Surges 15.38% to Day's High of Rs 267.75 — Outperforms Sector by 16.25 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-high-with-1538-surge-on-7-may-2026-3979872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_priceRelatedfactors_3979872.png",
        "date": "2026-05-07 12:45:49",
        "description": "The Sensex gained 0.48% on 7 May 2026, but Indoco Remedies Ltd outpaced the broader market with a remarkable 15.38% surge, reaching an intraday high of Rs 267.75. This 16.25-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide uplift."
      },
      {
        "title": "Indoco Remedies Ltd Surges 7.62% to Day's High of Rs 230 — Outperforms Sector by 4.02 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-high-with-762-surge-on-6-may-2026-3978052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_priceRelatedfactors_3978052.png",
        "date": "2026-05-06 15:30:52",
        "description": "The Sensex advanced 1.28% on 6 May 2026, yet Indoco Remedies Ltd outpaced both the benchmark and its sector with a 7.62% gain, reaching an intraday high of Rs 230. This 4.02 percentage-point outperformance signals a stock-specific momentum shift rather than a mere market tailwind."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3977627",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndocoRemediesL_mojoScore_3977627.png",
        "date": "2026-05-06 10:10:21",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Indoco Remedies Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-indoco-remedies-ltd-3967204",
        "imagepath": "",
        "date": "2026-04-28 23:16:05",
        "description": "The next results date for Indoco Remedies Ltd is scheduled for 07 May 2026...."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3962211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndocoRemediesL_mojoScore_3962211.png",
        "date": "2026-04-25 10:10:14",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Indoco Remedies Ltd Opens 9.05% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-opens-strong-with-significant-gap-up-on-15-apr-2026-3946967",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndocoRemediesL_gapup_3946967.png",
        "date": "2026-04-15 09:40:10",
        "description": ""
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3945672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndocoRemediesL_mojoScore_3945672.png",
        "date": "2026-04-14 10:10:14",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Indoco Remedies Gains 6.39%: Key Technical Shifts and Market Dynamics This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-gains-639-key-technical-shifts-and-market-dynamics-this-week-3943021",
        "imagepath": "",
        "date": "2026-04-11 17:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.190.00</p>\n                    <p><strong>8 Apr:</strong> Strong gap up with intraday high of Rs.204.50</p>\n                    <p><strong>10 Apr:</strong> Technical momentum shifts amid mixed signals, closes at Rs.202.15</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.190.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.202.15</div><div class=\"stat-change positive\">+6.39%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-lab..."
      }
    ],
    "total": 559,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "details": "Indoco Remedies Limited has informed the Exchange regarding a press release dated November 01, 2019, titled \"Approval of Glycopyrrolate ANDAfiled from Indoco's Goa Plant II\".",
      "source": "NSE",
      "caption": "Indoco Remedies Limited - Press Release",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Indoco Remedies Limited has informed the Exchange regarding 'Publication of Unaudited Financial Results for the quarter and half year ended 30.09.2019 in newspapers'.",
      "source": "NSE",
      "caption": "Indoco Remedies Limited - Updates",
      "datetime": "31-Oct-2019"
    },
    {
      "details": "Indoco Remedies Limited has informed the Exchange regarding a press release dated October 18, 2019, titled \"Indoco s Clinical Research Organisation receives zero 483s from USFDA\".",
      "source": "NSE",
      "caption": "Indoco Remedies Limited - Press Release",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(07 May 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indoco Remedies Q4 FY26: Mounting Losses Despite Revenue Growth Signal Deeper Operational Crisis

2026-05-07 17:46:23

Indoco Remedies Ltd., the Mumbai-based pharmaceutical company with a market capitalisation of ₹2,102 crores, reported a consolidated net loss of ₹21.64 crores for Q4 FY26, representing a sequential deterioration of 27.36% from the previous quarter's loss of ₹29.79 crores. On a year-on-year basis, the loss widened by 46.42% compared to the ₹40.39 crores loss in Q4 FY25. Despite posting quarterly revenue growth of 6.79% quarter-on-quarter and 21.89% year-on-year to reach ₹475.61 crores, the company's profitability remains severely impaired by escalating interest costs and operational inefficiencies.

Read full news article

Indoco Remedies Ltd Surges 15.38% to Day's High of Rs 267.75 — Outperforms Sector by 16.25 Percentage Points

2026-05-07 12:45:49

The Sensex gained 0.48% on 7 May 2026, but Indoco Remedies Ltd outpaced the broader market with a remarkable 15.38% surge, reaching an intraday high of Rs 267.75. This 16.25-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide uplift.

Read full news article

Indoco Remedies Ltd Surges 7.62% to Day's High of Rs 230 — Outperforms Sector by 4.02 Percentage Points

2026-05-06 15:30:52

The Sensex advanced 1.28% on 6 May 2026, yet Indoco Remedies Ltd outpaced both the benchmark and its sector with a 7.62% gain, reaching an intraday high of Rs 230. This 4.02 percentage-point outperformance signals a stock-specific momentum shift rather than a mere market tailwind.

Read full news article

Indoco Remedies Ltd is Rated Strong Sell

2026-05-06 10:10:21

Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

When is the next results date for Indoco Remedies Ltd?

2026-04-28 23:16:05

The next results date for Indoco Remedies Ltd is scheduled for 07 May 2026....

Read full news article

Indoco Remedies Ltd is Rated Strong Sell

2026-04-25 10:10:14

Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Indoco Remedies Ltd Opens 9.05% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-04-15 09:40:10

Read full news article

Indoco Remedies Ltd is Rated Strong Sell

2026-04-14 10:10:14

Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Indoco Remedies Gains 6.39%: Key Technical Shifts and Market Dynamics This Week

2026-04-11 17:00:04

Key Events This Week

6 Apr: Week opens at Rs.190.00

8 Apr: Strong gap up with intraday high of Rs.204.50

10 Apr: Technical momentum shifts amid mixed signals, closes at Rs.202.15

Week Open

Rs.190.00

Week Close

Rs.202.15

+6.39%

Read full news article

View All News